SMN1 and spinal muscular atrophy: Likewise, Zolgensma, a spinal muscular atrophy drug, is an AAV serotype 9 (capsid-type-9) that carries the survival motor neuron 1 (SMN1) gene to neurons via crossing the blood-brain barrier [30].